|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:704-705
© 2008 The American Association for Thoracic Surgery
Brief Communication |
Division of Thoracic Surgery, National Cancer Institute, Pascale Foundation, Naples, Italy
Received for publication August 22, 2007; accepted for publication October 17, 2007. * Address for reprints: Gaetano Rocco, MD, FRCS (Ed), FECTS, Division of Thoracic Surgery, National Cancer Institute, Pascale Foundation, Via M. Semmola, 81, 80131, Naples, Italy. (Email: Gaetano.Rocco{at}btopenworld.com).
The incidence of pneumothorax resulting from bronchoalveolar fistula complicating primary or secondary lung cancer ranges between 1% and 4%.1
Because of the rarity of this condition (4 cases out of 663 admissions for lung cancer [0.4%] during a 2-year period in our institution), preventing the accumulation of large numbered series, and the anecdotal nature of the reported cases, it has not been possible to investigate the pathophysiology and codify the possible therapeutic pathways indicated in the management of this particular type of pneumothorax.
An asymptomatic 52-year-old woman was referred to our attention for the detection on a chest radiogram of a total collapse of the right lung. After chest drain insertion, a computed tomographic scan showed a 5-cm right upper lesion with no obvious mediastinal nodal enlargement. The surgical approach entailed a right video-assisted thoracoscopy to rule out pleural dissemination; a subpleural tear in the pulmonary mass in the upper lobe was identified (
Figure 1). During the same session, a right upper lobectomy with complete mediastinal nodal dissection was performed via a right totally muscle-sparing hybrid (video-assisted/open) approach. The final pathologic report showed a pT2 N0 adenocarcinoma.
|
Extrathoracic malignant tumors can equally metastasize to the lung and virtually all histotypes have been associated with the onset of a pneumothorax. The etiopathogenesis of the pneumothorax can be multifactorial,1,2
and the same side as the cancer or the contralateral side can be affected depending on whether the actual tumor is the direct cause of the pneumothorax.
The treatment of this condition depends on the patient's age and performance status, cardiorespiratory functional reserve, and life expectancy. The ideal situation is to radically treat the cancer by a formal resection or by lung volume reduction surgery as per recent reports.3-5
However, when this is not feasible, alternative management aimed primarily at achieving pleurodesis3
should be considered after an adequate, but not prolonged, observation period (up to 2 weeks).
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |